These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 12914938)
1. Identification of sites in the cysteine-rich domain of the class P-III snake venom metalloproteinases responsible for inhibition of platelet function. Kamiguti AS; Gallagher P; Marcinkiewicz C; Theakston RD; Zuzel M; Fox JW FEBS Lett; 2003 Aug; 549(1-3):129-34. PubMed ID: 12914938 [TBL] [Abstract][Full Text] [Related]
2. Different regions of the class P-III snake venom metalloproteinase jararhagin are involved in binding to alpha2beta1 integrin and collagen. Tanjoni I; Evangelista K; Della-Casa MS; Butera D; Magalhães GS; Baldo C; Clissa PB; Fernandes I; Eble J; Moura-da-Silva AM Toxicon; 2010 Jun; 55(6):1093-9. PubMed ID: 20056118 [TBL] [Abstract][Full Text] [Related]
3. Function of disintegrin-like/cysteine-rich domains of atrolysin A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists. Jia LG; Wang XM; Shannon JD; Bjarnason JB; Fox JW J Biol Chem; 1997 May; 272(20):13094-102. PubMed ID: 9148922 [TBL] [Abstract][Full Text] [Related]
4. The reprolysin jararhagin, a snake venom metalloproteinase, functions as a fibrillar collagen agonist involved in fibroblast cell adhesion and signaling. Zigrino P; Kamiguti AS; Eble J; Drescher C; Nischt R; Fox JW; Mauch C J Biol Chem; 2002 Oct; 277(43):40528-35. PubMed ID: 12186858 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet aggregation by the recombinant cysteine-rich domain of the hemorrhagic snake venom metalloproteinase, atrolysin A. Jia LG; Wang XM; Shannon JD; Bjarnason JB; Fox JW Arch Biochem Biophys; 2000 Jan; 373(1):281-6. PubMed ID: 10620350 [TBL] [Abstract][Full Text] [Related]
6. Isolation, sequence analysis, and biological activity of atrolysin E/D, the non-RGD disintegrin domain from Crotalus atrox venom. Shimokawa K; Jia LG; Shannon JD; Fox JW Arch Biochem Biophys; 1998 Jun; 354(2):239-46. PubMed ID: 9637732 [TBL] [Abstract][Full Text] [Related]
7. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation. Serrano SMT; Wang D; Shannon JD; Pinto AFM; Polanowska-Grabowska RK; Fox JW FEBS J; 2007 Jul; 274(14):3611-3621. PubMed ID: 17578514 [TBL] [Abstract][Full Text] [Related]
8. Collagen binding is a key factor for the hemorrhagic activity of snake venom metalloproteinases. Moura-da-Silva AM; Ramos OH; Baldo C; Niland S; Hansen U; Ventura JS; Furlan S; Butera D; Della-Casa MS; Tanjoni I; Clissa PB; Fernandes I; Chudzinski-Tavassi AM; Eble JA Biochimie; 2008 Mar; 90(3):484-92. PubMed ID: 18096518 [TBL] [Abstract][Full Text] [Related]
9. Collagen-induced secretion-dependent phase of platelet aggregation is inhibited by the snake venom metalloproteinase jararhagin. Kamiguti AS; Moura-da-Silva AM; Laing GD; Knapp T; Zuzel M; Crampton JM; Theakston RD Biochim Biophys Acta; 1997 Apr; 1335(1-2):209-17. PubMed ID: 9133658 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-integrin by the snake venom metalloproteinase jararhagin. Kamiguti AS; Hay CR; Zuzel M Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):635-41. PubMed ID: 8973578 [TBL] [Abstract][Full Text] [Related]
11. A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation. Usami Y; Fujimura Y; Miura S; Shima H; Yoshida E; Yoshioka A; Hirano K; Suzuki M; Titani K Biochem Biophys Res Commun; 1994 May; 201(1):331-9. PubMed ID: 8198592 [TBL] [Abstract][Full Text] [Related]
12. Function of the cysteine-rich domain of the haemorrhagic metalloproteinase atrolysin A: targeting adhesion proteins collagen I and von Willebrand factor. Serrano SM; Jia LG; Wang D; Shannon JD; Fox JW Biochem J; 2005 Oct; 391(Pt 1):69-76. PubMed ID: 15929722 [TBL] [Abstract][Full Text] [Related]
13. Sequence and biological activity of catrocollastatin-C: a disintegrin-like/cysteine-rich two-domain protein from Crotalus atrox venom. Shimokawa K; Shannon JD; Jia LG; Fox JW Arch Biochem Biophys; 1997 Jul; 343(1):35-43. PubMed ID: 9210644 [TBL] [Abstract][Full Text] [Related]
14. Jararhagin ECD-containing disintegrin domain: expression in escherichia coli and inhibition of the platelet-collagen interaction. Moura-da-Silva AM; Línica A; Della-Casa MS; Kamiguti AS; Ho PL; Crampton JM; Theakston RD Arch Biochem Biophys; 1999 Sep; 369(2):295-301. PubMed ID: 10486149 [TBL] [Abstract][Full Text] [Related]
15. Mapping von Willebrand factor A domain binding sites on a snake venom metalloproteinase cysteine-rich domain. Pinto AF; Terra RM; Guimaraes JA; Fox JW Arch Biochem Biophys; 2007 Jan; 457(1):41-6. PubMed ID: 17118332 [TBL] [Abstract][Full Text] [Related]
17. BJ46a, a snake venom metalloproteinase inhibitor. Isolation, characterization, cloning and insights into its mechanism of action. Valente RH; Dragulev B; Perales J; Fox JW; Domont GB Eur J Biochem; 2001 May; 268(10):3042-52. PubMed ID: 11358523 [TBL] [Abstract][Full Text] [Related]
18. Complete amino acid sequence of kaouthiagin, a novel cobra venom metalloproteinase with two disintegrin-like sequences. Ito M; Hamako J; Sakurai Y; Matsumoto M; Fujimura Y; Suzuki M; Hashimoto K; Titani K; Matsui T Biochemistry; 2001 Apr; 40(14):4503-11. PubMed ID: 11284707 [TBL] [Abstract][Full Text] [Related]